Optogenetic Stimulation of the Superior Colliculus Confers Retinal Neuroprotection in a Mouse Glaucoma Model.


Journal

The Journal of neuroscience : the official journal of the Society for Neuroscience
ISSN: 1529-2401
Titre abrégé: J Neurosci
Pays: United States
ID NLM: 8102140

Informations de publication

Date de publication:
20 03 2019
Historique:
received: 06 04 2018
revised: 15 11 2018
accepted: 29 12 2018
pubmed: 19 1 2019
medline: 17 3 2020
entrez: 19 1 2019
Statut: ppublish

Résumé

Glaucoma is characterized by a progressive loss of retinal ganglion cells (RGCs) in the eye, which ultimately results in visual impairment or even blindness. Because current therapies often fail to halt disease progression, there is an unmet need for novel neuroprotective therapies to support RGC survival. Various research lines suggest that visual target centers in the brain support RGC functioning and survival. Here, we explored whether increasing neuronal activity in one of these projection areas could improve survival of RGCs in a mouse glaucoma model. Prolonged activation of an important murine RGC target area, the superior colliculus (SC), was established via a novel optogenetic stimulation paradigm. By leveraging the unique channel kinetics of the stabilized step function opsin (SSFO), protracted stimulation of the SC was achieved with only a brief light pulse. SSFO-mediated collicular stimulation was confirmed by immunohistochemistry for the immediate-early gene c-Fos and behavioral tracking, which both demonstrated consistent neuronal activity upon repeated stimulation. Finally, the neuroprotective potential of optogenetic collicular stimulation was investigated in mice of either sex subjected to a glaucoma model and a 63% reduction in RGC loss was found. This work describes a new paradigm for optogenetic collicular stimulation and a first demonstration that increasing target neuron activity can increase survival of the projecting neurons.

Identifiants

pubmed: 30655352
pii: JNEUROSCI.0872-18.2018
doi: 10.1523/JNEUROSCI.0872-18.2018
pmc: PMC6433760
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2313-2325

Informations de copyright

Copyright © 2019 the authors 0270-6474/19/392313-13$15.00/0.

Références

Neurosci Res. 1992 Jun;14(1):39-60
pubmed: 1380687
Science. 1993 Oct 29;262(5134):695-700
pubmed: 8235590
Development. 1997 Sep;124(17):3313-20
pubmed: 9310326
Exp Eye Res. 2016 Jun;147:105-113
pubmed: 27107795
Behav Brain Res. 1993 Dec 20;58(1-2):27-47
pubmed: 8136048
J Neurosci. 1986 Mar;6(3):723-33
pubmed: 3958791
Arch Ophthalmol. 2002 Oct;120(10):1268-79
pubmed: 12365904
Invest Ophthalmol Vis Sci. 2013 Feb 01;54(2):1236-43
pubmed: 23307964
BMC Bioinformatics. 2017 Nov 29;18(1):529
pubmed: 29187165
J Ocul Pharmacol Ther. 2018 Jan/Feb;34(1-2):129-133
pubmed: 28609158
Invest Ophthalmol Vis Sci. 2010 Jan;51(1):327-34
pubmed: 19710411
J Neurosci. 2000 Oct 1;20(19):7417-23
pubmed: 11007900
Brain Res Mol Brain Res. 2000 May 31;78(1-2):1-14
pubmed: 10891580
Neurochem Int. 1998 Oct;33(4):287-97
pubmed: 9840219
Eur J Pharmacol. 1985 Nov 5;117(2):149-58
pubmed: 3000802
Nat Commun. 2015 Apr 09;6:6756
pubmed: 25854147
PLoS One. 2015 Mar 26;10(3):e0121134
pubmed: 25811653
Nat Neurosci. 2000 Jun;3(6):533-5
pubmed: 10816306
J Neurobiol. 1995 Mar;26(3):403-12
pubmed: 7775973
J Neurosci. 2004 May 19;24(20):4796-806
pubmed: 15152040
Lancet. 2017 Nov 11;390(10108):2183-2193
pubmed: 28577860
Acta Ophthalmol. 2013 Feb;91(1):92-9
pubmed: 22336244
Invest Ophthalmol Vis Sci. 2011 Jan 05;52(1):36-44
pubmed: 20702815
Neuroscience. 2018 Jan 1;368:240-245
pubmed: 28642168
Gene Ther. 2011 May;18(5):517-27
pubmed: 21326331
Trends Neurosci. 1989 Apr;12(4):137-47
pubmed: 2470171
Invest Ophthalmol Vis Sci. 2016 Jan 1;57(1):81-93
pubmed: 26780312
Proc Natl Acad Sci U S A. 1998 Mar 31;95(7):3978-83
pubmed: 9520478
J Comp Neurol. 2015 Oct 1;523(14):2019-42
pubmed: 26012540
Exp Eye Res. 2016 Oct;151:96-106
pubmed: 27523467
Behav Brain Res. 1993 Dec 31;59(1-2):131-9
pubmed: 8155280
J Vis Exp. 2016 Mar 23;(109):e53731
pubmed: 27077732
PLoS One. 2015 Nov 11;10(11):e0142067
pubmed: 26560713
Cold Spring Harb Perspect Med. 2014 Jun 02;4(6):
pubmed: 24890835
Invest Ophthalmol Vis Sci. 2009 Aug;50(8):3860-8
pubmed: 19264888
Proc Natl Acad Sci U S A. 2014 Sep 2;111(35):12913-8
pubmed: 25136109
Brain Struct Funct. 2018 Jun;223(5):2073-2095
pubmed: 29372324
Neuroscience. 2013 Jan 15;229:55-70
pubmed: 23159315
Invest Ophthalmol Vis Sci. 2003 Oct;44(10):4357-65
pubmed: 14507880
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
Handb Exp Pharmacol. 2014;220:67-100
pubmed: 24668470
Prog Retin Eye Res. 2012 Nov;31(6):702-19
pubmed: 22871543
Invest Ophthalmol Vis Sci. 2014 Feb 03;55(2):658-65
pubmed: 24398098
J Neurophysiol. 2015 Apr 1;113(7):2400-7
pubmed: 25632081
Science. 2015 Jun 26;348(6242):1472-7
pubmed: 26113723
Exp Eye Res. 2010 Sep;91(3):415-24
pubmed: 20599961
Neuroscience. 1982 Jan;7(1):207-22
pubmed: 7078726
Semin Cell Dev Biol. 2014 Jul;31:57-63
pubmed: 24709025
Proc Natl Acad Sci U S A. 2000 Jul 18;97(15):8584-9
pubmed: 10890902
J Neurophysiol. 2016 Aug 1;116(2):602-10
pubmed: 27169509
EMBO J. 1990 Nov;9(11):3545-50
pubmed: 2170117
Exp Eye Res. 2010 Jan;90(1):168-83
pubmed: 19835874
Invest Ophthalmol Vis Sci. 2013 Feb 01;54(2):974-85
pubmed: 23307961
J Neurosci. 1998 Mar 15;18(6):2097-107
pubmed: 9482796
Neurophotonics. 2015 Jul;2(3):031209
pubmed: 26839901
Prog Retin Eye Res. 2012 Jan;31(1):1-27
pubmed: 21946033
Exp Eye Res. 2015 Dec;141:111-24
pubmed: 26070986
Exp Eye Res. 2016 Apr;145:235-247
pubmed: 26791081
Behav Brain Res. 2013 Oct 15;255:55-63
pubmed: 23643689
Nature. 2016 Jun 01;534(7606):206-12
pubmed: 27279213
Exp Eye Res. 2011 Apr;92(4):260-7
pubmed: 21315070
Invest Ophthalmol Vis Sci. 2010 Apr;51(4):2051-9
pubmed: 19933193
Exp Eye Res. 2009 Apr;88(4):808-15
pubmed: 19217904
Exp Eye Res. 2011 May;92(5):377-87
pubmed: 21354138
Philos Trans R Soc Lond B Biol Sci. 2006 Sep 29;361(1473):1545-64
pubmed: 16939974
Nature. 2011 Jul 27;477(7363):171-8
pubmed: 21796121
J Histochem Cytochem. 2000 May;48(5):671-84
pubmed: 10769051
Annu Rev Vis Sci. 2016 Oct 14;2:235-254
pubmed: 28532352
Can J Ophthalmol. 2007 Apr;42(2):278-87
pubmed: 17392853
Annu Rev Vis Sci. 2017 Sep 15;3:91-120
pubmed: 28731838
Neurosci Biobehav Rev. 1994 Fall;18(3):339-46
pubmed: 7984352

Auteurs

Emiel Geeraerts (E)

Laboratory of Neural Circuit Development and Regeneration, Department of Biology, KU Leuven, 3000 Leuven, Belgium.
Leuven Brain Institute, KU Leuven, 3000 Leuven, Belgium.

Marie Claes (M)

Laboratory of Neural Circuit Development and Regeneration, Department of Biology, KU Leuven, 3000 Leuven, Belgium.
Leuven Brain Institute, KU Leuven, 3000 Leuven, Belgium.

Eline Dekeyster (E)

Laboratory of Neural Circuit Development and Regeneration, Department of Biology, KU Leuven, 3000 Leuven, Belgium.
Leuven Brain Institute, KU Leuven, 3000 Leuven, Belgium.

Manuel Salinas-Navarro (M)

Laboratory of Neural Circuit Development and Regeneration, Department of Biology, KU Leuven, 3000 Leuven, Belgium.
Leuven Brain Institute, KU Leuven, 3000 Leuven, Belgium.

Lies De Groef (L)

Laboratory of Neural Circuit Development and Regeneration, Department of Biology, KU Leuven, 3000 Leuven, Belgium.
Leuven Brain Institute, KU Leuven, 3000 Leuven, Belgium.

Chris Van den Haute (C)

Leuven Brain Institute, KU Leuven, 3000 Leuven, Belgium.
Laboratory for Neurobiology and Gene Therapy, Department of Neurosciences, KU Leuven, 3000 Leuven, Belgium.
Viral Vector Core Leuven, KU Leuven, 3000 Leuven, Belgium, and.

Isabelle Scheyltjens (I)

Leuven Brain Institute, KU Leuven, 3000 Leuven, Belgium.
Laboratory of Neuroplasticity and Neuroproteomics, Department of Biology; KU Leuven, 3000 Leuven, Belgium.

Veerle Baekelandt (V)

Leuven Brain Institute, KU Leuven, 3000 Leuven, Belgium.
Laboratory for Neurobiology and Gene Therapy, Department of Neurosciences, KU Leuven, 3000 Leuven, Belgium.

Lutgarde Arckens (L)

Leuven Brain Institute, KU Leuven, 3000 Leuven, Belgium.
Laboratory of Neuroplasticity and Neuroproteomics, Department of Biology; KU Leuven, 3000 Leuven, Belgium.

Lieve Moons (L)

Laboratory of Neural Circuit Development and Regeneration, Department of Biology, KU Leuven, 3000 Leuven, Belgium, lieve.moons@kuleuven.be.
Leuven Brain Institute, KU Leuven, 3000 Leuven, Belgium.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH